Please assess the completion status of the following clinical trial:

Trial Title: A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 21-45 years old,~* weight 40-90 kg,~* height 145-170 cm~Exclusion Criteria:~* contraindications to spinal anaesthesia,~* allergy to drugs used in the study, and~* those with uncontrolled medical conditions such as hypertension, diabetes mellitus, and cardiovascular disease

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- vasopressor delivery automated system (Type: EXPERIMENTAL): vasopressor delivery automated system administering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique
- manual vasopressor delivery (Type: ACTIVE_COMPARATOR): manual bolus delivering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique

Based on this trial design, predict the completion outcome and termination type (if applicable).